| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 80.45▲ | 81.05▼ | 81.37▼ | 84.76▼ | 82.25▼ |
| MA10 | 80.81▼ | 81.66▼ | 82.30▼ | 82.29▼ | 87.06▼ |
| MA20 | 81.07▼ | 82.61▼ | 83.36▼ | 80.34▲ | 68.96▲ |
| MA50 | 82.30▼ | 84.83▼ | 84.32▼ | 85.25▼ | 52.89▲ |
| MA100 | 82.94▼ | 84.00▼ | 79.26▲ | 67.65▲ | 49.37▲ |
| MA200 | 84.94▼ | 79.04▲ | 83.42▼ | 55.21▲ | 41.58▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | -0.112▼ | -0.407▼ | 0.571▲ | 0.342▲ |
| RSI | 39.011▼ | 35.336▼ | 33.505▼ | 48.396▼ | 58.695▲ |
| STOCH | 6.956▼ | 14.949▼ | 8.535▼ | 76.953 | 66.086 |
| WILL %R | -73.874 | -89.606▼ | -91.471▼ | -42.022 | -35.311 |
| CCI | -82.779 | -135.636▼ | -156.937▼ | 30.167 | 36.180 |
|
Friday, April 03, 2020 03:38 PM
Acceleron Pharma (NASDAQ:XLRN) and collaboration partner Bristol-Myers Squibb (NYSE:BMY) announce the FDA nod for Reblozyl (luspatercept-aamt) for the treatment of anemia in certain adult patients wit ...
|
|
Friday, April 03, 2020 02:29 PM
Acceleron Pharma (NASDAQ:XLRN) and collaboration partner Bristol-Myers Squibb (NYSE:BMY) announce the FDA nod for Reblozyl (luspatercept-aamt) for the treatment of anemia in certain adult patients wit ...
|
|
Tuesday, March 31, 2020 08:28 PM
Shares of Acceleron Pharma Inc (NASDAQ:XLRN) have been assigned a consensus recommendation of “Buy” from the seventeen research firms that are currently covering the firm, MarketBeat Ratings reports.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/04/20 | 82.56 | 84.11 | 80.10 | 80.78 | 343,300 |
| 02/04/20 | 82.62 | 85.45 | 82.25 | 83.60 | 433,400 |
| 01/04/20 | 89.00 | 89.85 | 82.83 | 84.01 | 740,400 |
| 31/03/20 | 85.54 | 91.13 | 84.68 | 89.87 | 890,300 |
| 30/03/20 | 87.13 | 87.13 | 83.52 | 85.52 | 478,100 |
| 27/03/20 | 79.42 | 87.98 | 79.42 | 87.05 | 831,000 |
| 26/03/20 | 79.05 | 82.78 | 76.62 | 82.03 | 569,900 |
| 25/03/20 | 80.11 | 83.18 | 78.28 | 79.05 | 559,300 |
| 24/03/20 | 73.90 | 80.62 | 72.58 | 80.14 | 623,300 |
| 23/03/20 | 73.02 | 74.66 | 67.15 | 70.82 | 778,400 |
|
|
||||
|
|
||||
|
|